1. Metabolic Enzyme/Protease Cell Cycle/DNA Damage Autophagy Apoptosis
  2. Endogenous Metabolite PERK Atg8/LC3 Autophagy Bcl-2 Family Apoptosis Eukaryotic Initiation Factor (eIF) ATF6
  3. L-Azetidine-2-carboxylic acid

L-Azetidine-2-carboxylic acid  (Synonyms: L-アゼチジン-2-カルボン酸; L-トリメチレンイミン-2-カルボン酸)

製品番号: HY-W050044 純度: 99.97%
COA 取扱説明書 Technical Support

L-Azetidine-2-carboxylic acid is a proline analog. L-Azetidine-2-carboxylic acid upregulates the lipid autophagy marker LC3-II via activation of the PERK pathway. L-Azetidine-2-carboxylic acid increases pro-apoptotic BAX protein. L-Azetidine-2-carboxylic acid induces ATF6 cleavage and upregulates phosphorylated eIF2α levels. L-Azetidine-2-carboxylic acid induces ER stress, inducing protein misfolding and aggregation. L-Azetidine-2-carboxylic acid shows teratogenic, pro-inflammatory and pro-apoptotic effects.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

L-Azetidine-2-carboxylic acid

L-Azetidine-2-carboxylic acid 構造式

CAS 番号 : 2133-34-8

容量 価格(税別) 在庫状況 数量
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in Water
ready for reconstitution
USD 27 在庫あり
Solution
10 mM * 1 mL in Water USD 27 在庫あり
Solid
100 mg $25 在庫あり
500 mg $50 在庫あり
1 g $75 在庫あり
5 g   お問い合わせ  
10 g   お問い合わせ  

* アイテムを追加する前、数量をご選択ください

This product is a controlled substance and not for sale in your territory.

カスタマーレビュー

Based on 1 publication(s) in Google Scholar

Other Forms of L-Azetidine-2-carboxylic acid:

Top Publications Citing Use of Products

Endogenous Metabolite アイソフォーム固有の製品をすべて表示:

Bcl-2 Family アイソフォーム固有の製品をすべて表示:

  • 生物活性

  • 純度とドキュメンテーション

  • 参考文献

  • カスタマーレビュー

製品説明

L-Azetidine-2-carboxylic acid is a proline analog. L-Azetidine-2-carboxylic acid upregulates the lipid autophagy marker LC3-II via activation of the PERK pathway. L-Azetidine-2-carboxylic acid increases pro-apoptotic BAX protein. L-Azetidine-2-carboxylic acid induces ATF6 cleavage and upregulates phosphorylated eIF2α levels. L-Azetidine-2-carboxylic acid induces ER stress, inducing protein misfolding and aggregation. L-Azetidine-2-carboxylic acid shows teratogenic, pro-inflammatory and pro-apoptotic effects[1][2][3][4][5][6][7][8][9].

IC50 & Target

Human Endogenous Metabolite

 

体外実験

L-azetidine-2-carboxylic acid increases glycosylations of collagen in chick-embryo tendon cells[1].
L-azetidine-2-carboxylic acid (5 mM, 9 h) induces ATF6 cleavage and upregulates BiP expression and phosphorylated eIF2α levels in HeLa cells[2].
L-azetidine-2-carboxylic acid (1-10 mM) reduces L-[U-14-C]proline incorporation into hemoglobin (25, 58, and 72% for 1, 5, and 10 mM, , respectively) in rabbit reticulocytes[3].
L-azetidine-2-carboxylic acid (350 μg/egg, daily, 9 days) prevents expression of the chondrogenic phenotype in embryonated eggs of Gallus domesticus[4].
L-azetidine-2-carboxylic acid (0-2000 µM, 6-24 h) shows pro-inflammatory and pro-apoptotic effects in BV2 microglial cells[5].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Apoptosis Analysis[5]

Cell Line: BV2 cells
Concentration: 1000 µM
Incubation Time: 6, 24 h
Result: Did not affect Bcl2 protein expression.
Increased pro-apoptotic BAX protein both at 6 and 24 h.
Increased BAX/Bcl2 ratio after 6 h.

Real Time qPCR[5]

Cell Line: BV2 cells
Concentration: 1000 µM
Incubation Time: 6, 24 h
Result: Induced CD68 after 6 h.
Up-regulated MMP-9, but only at 24 h.
体内実験

L-azetidine-2-carboxylic acid (200-600 mg/kg, i.p., given on gestational days 7-12) exhibits teratogenic effects in hamster fetuses[6].
L-azetidine-2-carboxylic acid (300 mg/kg, i.p., on day 8 of pregnancy) exhibits teratogenic effects on the skeletal system in rats[7].
L-azetidine-2-carboxylic acid (300 mg/kg, i.p., single) causes disrupted dentinogenesis in rats and mice[8].
L-azetidine-2-carboxylic acid (200 mg/kg, twice daily for 2 days) retards lung growth and surfactant synthesis in fetal rats[9].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Eight-week-old pregnant virgin Wistar rats[7]
Dosage: 300 mg/kg
Administration: Intraperitoneal injection (i.p.), on day 8,9, 10,11, 12 or 13 of pregnancy
Result: Showed skeletal malformations, skeletal variations, delayed ossification and growth retardation.
Showed a higher mortality.
分子量

101.10

分子式

C4H7NO2

CAS 番号
Appearance

Solid

Color

White to off-white

SMILES

O=C([C@H]1NCC1)O

Structure Classification
Initial Source
輸送条件

Room temperature in continental US; may vary elsewhere.

保管条件

4°C, protect from light, stored under nitrogen

*In solvent : -80°C, 6 months; -20°C, 1 month (protect from light, stored under nitrogen)

溶剤 & 溶解度
体外: 

H2O : 100 mg/mL (989.12 mM; Need ultrasonic)

DMSO : < 1 mg/mL (insoluble or slightly soluble)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 9.8912 mL 49.4560 mL 98.9120 mL
5 mM 1.9782 mL 9.8912 mL 19.7824 mL
10 mM 0.9891 mL 4.9456 mL 9.8912 mL
View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light, stored under nitrogen). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.

  • Molarity Calculator

  • Dilution Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass
=
Concentration
×
Volume
×
Molecular Weight *

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

一般には略語で表示されます:C1V1 = C2V2

濃度 (開始)

C1

×
体積 (開始)

V1

=
濃度 (終了)

C2

×
体積 (終了)

V2

体内:

For the following dissolution methods, please prepare the working solution directly. It is recommended to prepare fresh solutions and use them promptly within a short period of time.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

  • Protocol 1

    Add each solvent one by one:  PBS

    Solubility: 100 mg/mL (989.12 mM); Clear solution; Need ultrasonic

In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

g

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Calculation results:
Working solution concentration: mg/mL
This product has good water solubility, please refer to the measured solubility data in water/PBS/Saline for details.
The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only.If necessary, please contact MedChemExpress (MCE).
純度とドキュメンテーション

純度: 99.97%

参考文献

Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light, stored under nitrogen). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
H2O 1 mM 9.8912 mL 49.4560 mL 98.9120 mL 247.2799 mL
5 mM 1.9782 mL 9.8912 mL 19.7824 mL 49.4560 mL
10 mM 0.9891 mL 4.9456 mL 9.8912 mL 24.7280 mL
15 mM 0.6594 mL 3.2971 mL 6.5941 mL 16.4853 mL
20 mM 0.4946 mL 2.4728 mL 4.9456 mL 12.3640 mL
25 mM 0.3956 mL 1.9782 mL 3.9565 mL 9.8912 mL
30 mM 0.3297 mL 1.6485 mL 3.2971 mL 8.2427 mL
40 mM 0.2473 mL 1.2364 mL 2.4728 mL 6.1820 mL
50 mM 0.1978 mL 0.9891 mL 1.9782 mL 4.9456 mL
60 mM 0.1649 mL 0.8243 mL 1.6485 mL 4.1213 mL
80 mM 0.1236 mL 0.6182 mL 1.2364 mL 3.0910 mL
100 mM 0.0989 mL 0.4946 mL 0.9891 mL 2.4728 mL

* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.

  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

質量   濃度   体積   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

一般には略語で表示されます:C1V1 = C2V2

濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

最近チェックした製品:

オンラインお問い合わせ

Your information is safe with us. * Required Fields.

製品名

 

カスタマ需要量 *

お名前 *

 

タイトル

メールアドレス *

 

電話番号 *

デパートメント

 

組纖名 *

市区町村

都道府県

国或いは地域 *

     

必ず会社名を記載ください。個人への返信は行いません。

備考

バルクお問い合わせ

Inquiry Information

製品名:
L-Azetidine-2-carboxylic acid
製品番号:
HY-W050044
数量:
MCE 日本正規代理店: